"We know that Reframe Cancer’s specialist knowledge will be invaluable to our existing members and that they will also benefit from the networking opportunities, research, and insights that are central to being a GRID member"
- Colin Fitzgerald - chair of GRiD
Group Risk Development (GRiD), has announced that cancer navigation and support specialists, Reframe Cancer, has become its latest member.
The experts in workplace cancer specialise in helping employees balance a range of complex emotional, clinical, financial and practical issues at a time when they may feel overwhelmed. As well as working directly with employers, Reframe Cancer also partners with insurers to deliver a personalised service to their customers affected by the disease.
According to GRiD’s figures for 2023, cancer was once again the main cause of claim across all three types of group risk products, accounting for 68% of group critical illness claims, 39% of group life claims and 24% of group income protection claims.
Mark Stephenson, CEO of Reframe Cancer said: “GRiD offers us a platform to make connections and develop relationships that will help drive knowledge and awareness of cancer support, its impact on patient outcomes and the added value it brings to insurers and employers. We hope to collaborate with other like-minded organisations and together, create a more efficient and effective pathway for navigating cancer care.”
Colin Fitzgerald, chair of GRiD added: “We know that Reframe Cancer’s specialist knowledge will be invaluable to our existing members and that they will also benefit from the networking opportunities, research, and insights that are central to being a GRID member.”
